ALS

For decades, a diagnosis of amyotrophic lateral sclerosis has carried with it an almost unbearable certainty. Patients and families are told to prepare for relentless decline, loss of independence, and a future measured not in years, but often in months. Treatments approved over the years have offered only modest extensions of life, with effects so …

A drug already carrying years of human safety data from trials for Parkinson’s disease and ALS just produced a striking result in a different disease altogether. Researchers at Monash University gave the compound to mice bred to develop Alzheimer’s, then watched what happened inside the animals’ brains over eight weeks of treatment. Numbers from that …